Viral hepatitis (Q70377889)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125513%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

review article

1 reference

title

Viral hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125513%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

W F Balistreri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125513%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

publication date

1 April 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125513%20AND%20SRC:MED&resulttype=core&format=json

Pediatric Clinics of North America

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125513%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125513%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125513%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

375-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125513%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B virus transmission between heterosexuals

10 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Serological response to the hepatitis delta virus in hepatitis D.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Immune response in neonates to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

A military community outbreak of hepatitis type A related to transmission in a child care facility

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis Delta Virus Infection and Labrea Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

The Chronic Sequelae of Non-A, Non-B Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

A "NEW" ANTIGEN IN LEUKEMIA SERA

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Prognosis of chronic hepatitis B transmitted from HBsAg positive mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Liver cirrhosis associated with chronic hepatitis B virus infection in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Transfusion-associated hepatitis and AIDS. What is the risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Transmission of hepatitis B virus to classroom contacts of mentally retarded carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Epidemiologic aspects of Santa Marta hepatitis over a 40-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Epidemiological aspects of the transmission of hepatitis B by HBsAg-positive adopted children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

A multicenter, prospective study of posttransfusion hepatitis in Milan

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Delta hepatitis in the Los Angeles area: a report of 126 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Epidemic non-A, non-B hepatitis in patients from Pakistan.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Gianotti-Crosti syndrome associated with infections other than hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Nosocomial hepatitis A infection in a paediatric intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Infection with the delta agent in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Non-A, maybe-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

The safety of the hepatitis B vaccine. Inactivation of the AIDS virus during routine vaccine manufacture

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Occurrence of hepatitis A, B, and non-A/non-B in the United States. CDC sentinel county hepatitis study I

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Viral hepatitis type B during pregnancy, the neonatal period, and infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Papular acrodermatitis of childhood. An Australia antigen disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Serologic investigation of an outbreak of hepatitis A in a rural day-care center

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Nosocomial hepatitis A.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

The here and now of hepatitis B immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Risk factors for hepatitis A in day-care centers

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis in day care centers: epidemiology and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis A in day-care centers. A community-wide assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B virus transmission in nursery schools

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B virus DNA in serum of pregnant women with HBsAg and HBeAg or antibodies to HBe.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B Vaccination in Down's Syndrome and Other Mentally Retarded Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Yeast recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Chronic type B hepatitis and the "healthy" HBsAg carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Perinatal transmission of hepatitis B virus: role of maternal HBeAg and anti-HBc IgM.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B vaccination: how long does protection last?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Prevention of perinatal transmission of hepatitis B virus (HBV) to children of e antigen-positive HBV carrier mothers by hepatitis B immune globulin and HBV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Chronic delta infection and liver biopsy changes in chronic active hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Incidence and severity of viral hepatitis in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B carriers in the classroom

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Viral hepatitis, type B (MS-2 strain). Studies on active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Viral hepatitis, type B. Studies on natural history and prevention re-examined

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

The natural history of infectious hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Immunogenicity of hepatitis B virus vaccine in healthy Chinese neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Type A viral hepatitis. New developments in an old disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatocellular carcinoma in young, mentally retarded HBsAg carriers without cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Occupational risk of hepatitis B from institutionalized mentally retarded HBsAg carriers: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

A virus in Beechey ground squirrels that is related to hepatitis B virus of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Passive-active immunisation of neonates of HBsAg positive carrier mothers: preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Vaccine against human hepatitis B virus prepared from antigen derived from human hepatoma cells in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Human hepatitis B vaccine from recombinant yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Liver disease complicating severe haemophilia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Very-low-dose hepatitis B vaccine in newborn infants: an economic option for control in endemic areas

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B virus infection in multitransfused haemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Posttransfusion hepatitis A in a neonatal intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Seroimmunologic classification of chronic hepatitis in 57 children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Modern aspects of the morphology of viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Relation of the hepatitis B virus carrier state to hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B Immune Globulin: Final Report of a Controlled, Multicenter Trial of Efficacy in Prevention of Dialysis-Associated Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Progress toward a live, attenuated human hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Studies in Chimpanzees of Live, Attenuated Hepatitis A Vaccine Candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Viral hepatitis B in neonates and infants

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B surface antigenemia in North American children with membranous glomerulonephropathy. Southwest Pediatric Nephrology Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Vertical Transmission of Hepatitis B Antigen in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Three recently described animal virus models for human hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Hepatitis B vaccine: different regimens for different geographic regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

The three viruses of non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Maternal transmission of duck hepatitis B virus in pedigree Pekin ducks

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

A large outbreak of hepatitis A in a day-care center: association with non-toilet-trained children and persistence of IgM antibody to hepatitis A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Routine hepatitis screening in adolescent pregnancies: is it cost effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Vertical transmission of hepatitis B surface antigen in carrier mothers in two west London hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Prednisolone in HBsAg-positive chronic active hepatitis: histologic evaluation in a controlled prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Primary hepatocellular carcinoma and hepatitis B infection during childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Overview of clinical studies with hepatitis B vaccine made by recombinant DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Perinatal transmission of the hepatitis B virus and of the HBV-associated delta agent from mothers to offspring in northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

In vitro hepatitis B virus infection of human bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Perinatal transmission of hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

Prevention of hepatitis B infection by hepatitis B immune globulin in infants born to mothers with acute hepatitis during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936436-7

7 January 2021

10.1016/S0031-3955(16)36436-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125513%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125513%20AND%20SRC:MED&resulttype=core&format=json